Ignite International Brands, Ltd. (CSE:BILZ, OTCQX: BILZF) (“IGNITE” or the “Company”) is pleased to announce today the appointment of Mr. Thomas Kofman, an independent, non-executive director, to its board of directors.

Mr. Kofman has over thirty-five years of experience in capital markets on both the debt and equity side, working both as agent and principal. Mr. Kofman has served in a number of senior management positions with a variety of companies, including his role as a founding officer of the first real estate investment trust (“REIT”) in Canada. Mr. Kofman also founded and served as Chairman of M Partners Inc., a full-service institutional investment bank. During his tenure at M Partners Inc., Mr. Kofman oversaw over $6 billion dollars of global transactions within numerous industry verticals, including establishing one of the first publicly traded companies in the Canadian medical marijuana space.


Mr. Kofman is a Chartered Professional Accountant and currently serves as a director of three companies in various industries. Mr. Kofman works closely with Erase Cancer, a charity founded by his family, and in the past six years has raised over $500,000 for Camp Ooch; a camp for children suffering from cancer.

“IGNITE is very pleased to have someone of Mr. Kofman’s character and caliber join our board. Over and above his extensive experience in both the capital markets and the cannabis space, Mr. Kofman truly understands IGNITE’s brand strategy and shares the management team’s vision and enthusiasm about what the IGNITE brand can achieve globally,” said President, Curtis Heffernan.

In conjunction with his appointment, Mr. Kofman will be granted 100,000 stock options, vesting over three (3) years from the date of grant, to purchase subordinate voting shares of IGNITE at an exercise price of $2.25 per share.

In concert with Mr. Kofman’s appointment, Mr. Scott Rohleder announced his retirement from IGNITE’s board of directors. The entire IGNITE team wishes to thank Mr. Rohleder for his incredibly valuable contribution during his tenure and wish him the best of luck in his future endeavors.

ABOUT IGNITE

IGNITE is a CSE-listed and OTCQX traded company operating in permissible CBD and cannabis sectors in addition to other product categories. IGNITE intends to expand its business, which currently includes branding, marketing, licensing, sales and distribution, across the United States, Canada, the United Kingdom and Mexico by leveraging multiple product platforms. The Company intends to affect this expansion through brand leverage, product development, targeted marketing and strategic supply chain partnerships in each of its active and target jurisdictions.

For further information, please contact:
IGNITE Investor Relations
Tel: 905-669-0212
Email: ir@ignite.co

Click here to connect with Ignite International Brands (CSE:BILZ) for an Investor Presentation

SOURCE

 

Cannabis - Will The Fortune 500 Join The Party?

 
Our Exclusive FREE Report Contains Information You NEED To Know About Cannabis Stock Investing!
 
  • The Cannabis Derivatives are derived from Avicanna’s cultivation and extraction infrastructure in Santa Marta, Colombia designed to supply partner companies and the manufacture of Avicanna’s own finished products.

Avicanna Inc. (” Avicanna ” or the ” Company “) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN), a biopharmaceutical company focused on the development, manufacturing and commercialization of plant-derived cannabinoid-based products, is pleased to announce that, through its majority owned Colombian subsidiary, Santa Marta Golden Hemp S.A.S. (“ SMGH ”), it has completed a commercial exports of CBD Isolate and CBD full spectrum psychoactive cannabis resin (the “ Cannabis Derivatives ”) to a leading Chilean homeopathic and naturopathic pharmaceutical company.

The Cannabis Derivatives, branded as Aureus™, are cultivated, extracted, and manufactured by SMGH. In addition, for Avicanna’s global input needs, SMGH also supplies other pharmaceutical and cosmetics companies with cannabinoids including CBD, THC, and rare cannabinoids such as CBG in addition to supplying global cultivation companies with standardized and feminized seeds. This new export to Chile is a recurring order and part of on-going relationship with an established homeopathic Chilean company.

Keep reading... Show less

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX:WEED, NASDAQ:CGC) will release its financial results for the second quarter fiscal year 2022 ended September 30, 2021 before financial markets open on November 5, 2021 .

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco Labs” or “the Company”), a vertically integrated multistate operator and the number one U.S. wholesaler of branded cannabis products, announced today the opening of a new Sunnyside dispensary in Wyomissing, Pennsylvania. Wyomissing will be Cresco Labs’ fifth dispensary in Pennsylvania and 38 th nationwide.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211021006075/en/

Keep reading... Show less

The world of cannabis consumption is set to change radically, thanks in large part to the advancement of state-of-the-art research on the plant itself.

Medical cannabis products have already allowed many new users to discover the plant’s potential, but decisive research will help build a foundation for more sophisticated medical offerings.

Keep reading... Show less

ADASTRA HOLDINGS LTD. ENGAGES HYBRID FINANCIAL LTD.

Adastra Holdings Ltd. (formerly Phyto Extractions Inc.) (CSE: XTRX) (FRA: D2EP) (“Adastra”, or the “Company”) is pleased to announce that it has retained Hybrid Financial Ltd. (“Hybrid”) to provide marketing services to the Company. Hybrid has been engaged to heighten market and brand awareness for Adastra and to broaden the Company’s reach within the investment community.

Keep reading... Show less